MedDataX Logo

Use of Methylphenidate in Children and Adolescents in France

NCT ID: NCT03371069

Last Updated: 2017-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of methylphenidate in children and adolescents in France from 2010 to 2015

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To describe the use of methylphenidate in children and adolescents in France from 2010 to 2015

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Use of Methylphenidate in Children and Adolescents

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

methylphenidate drug utilisation study pediatrics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

users of methylphenidate

Children and adolescents who are users of methylphenidate, 2010 to 2015

users of methylphenidate

Intervention Type OTHER

Children and adolescents who are users of methylphenidate, 2010 to 2015

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

users of methylphenidate

Children and adolescents who are users of methylphenidate, 2010 to 2015

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children and adolescents (0-17 years)
* registered in the French Health Insurance Database from 2012-2015
Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Florentia Kaguelidou, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Robert Debré, APHP

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15FKU-MPH

Identifier Type: -

Identifier Source: org_study_id